Results 241 to 250 of about 82,941 (302)

Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Pan H, Huang Z, Li A, Li M, Li Y, Lin Y, Cai J.   +6 more
europepmc   +1 more source

Triple‐Negative Breast Cancer Versus Non‐Triple‐Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal‐Like Triple‐Negative Breast Cancer

ChemMedChem, Volume 21, Issue 9, 14 May 2026.
The anticancer activity of the complexes Pd3Spd2, Pt3Spd2, Pt2Put2(NH3)4 and Pd2Put2 against human TNBC, non‐TNBC and healthy breast cells was evaluated. The metabolic impact of the most promising metal complexes—Pd3Spd2 and Pt2Put2(NH3)4—was further assessed using vibrational microspectroscopies, providing detailed insights into the drug‐induced ...
Clara B. Martins, Maria P. M. Marques, Luís A. E. Batista de Carvalho, Ana L. M. Batista de Carvalho   +3 more
wiley   +1 more source

Multi-omics analysis of ST3GAL4-mediated lacto/neolacto glycosphingolipid metabolism reveals immune evasion and poor prognosis in TNBC. [PDF]

Front Immunol
Zhang Y, Wang S, Yu X, Sun K, Wang S.
europepmc   +1 more source

Immunotherapy innovations in triple-negative breast cancer: targeting checkpoints, combinations, and biomarkers. [PDF]

Oncol Rev
Wang ZX, Chu JH, Wang YR, Huang LY, Qian MP.   +4 more
europepmc   +1 more source

The role of pluripotency regulators in triple-negative breast cancer immune response. [PDF]

Front Genet
López-Santana C, Mendez-Rivera F, Bernal-Estévez DA.   +2 more
europepmc   +1 more source

Huaier Polysaccharides Sensitize Anti-PD-L1 Therapy via Promoting Antitumor Immune Response in Triple-Negative Breast Cancer. [PDF]

Int J Biol Sci
Zhou LX, Wu ZW, Tian Y, Luo KF, Pan QW, Xi YY, Tang P, Zeng LJ, Zhong L, Jiang J, Zhang Y, Hou L, Zheng H, Wang MH.   +13 more
europepmc   +1 more source

Full-Length Transcriptome Profiles Reveal the Molecular Function of Oncogene HNRNPA2B1 in Triple-Negative Breast Cancer. [PDF]

Cancer Med
Yi L, Li Y, Ou J.
europepmc   +1 more source

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025. [PDF]

Curr Oncol
Simmons C, Khan OF, Brezden-Masley C, Cescon DW, Joy AA, LeVasseur N, Jerzak KJ, Gelmon KA, Sehdev S, Chia S, Webster M, Edwards S, Kumar A, Cao JQ, Boileau JF, Laing K, Bouganim N, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada.   +18 more
europepmc   +1 more source